Loading data for SNOA — first visit, this takes a few seconds.
Sonoma Pharmaceuticals, Inc. (SNOA)
NasdaqCM: SNOA
· Real-Time Price · USD
1.29
-0.02 (-1.53%)
At close: Sep 02, 2026, 8:00 PM
1.29
+0.00%
After-hours: 4:10 PM
The price, the headline numbers and the latest news, in one place.
Sonoma Pharmaceuticals, Inc. (SNOA) Stock Price, Analysis & Data
No data available
| Bid | 0.96 |
| Market Cap | 6.18M |
| Revenue (ttm) | 21.9M |
| Net Income (ttm) | -2.26M |
| 1.29 | |
| -1.22 | |
| n/a | |
| -2.3 | |
| P/B (ttm) | 0.75 |
| P/S (ttm) | 0.28 |
| Earnings Date | n/a |
| Ask | 1.84 |
| Volume | 93,836 |
| Avg. Volume (20D) | 158,187 |
| Open | 1.28 |
| Previous Close | 1.31 |
| Day's Range | 1.27 - 1.31 |
| 52-Week Range | 0.85 - 4.77 |
| Analyst | n/a |
| Price Target | n/a |
| Dividends | n/a |
| Ex-Dividend Date | n/a |
About SNOA
Sonoma Pharmaceuticals, Inc. develops and produces stabilized hypochlorous acid (HOCl) products for wound and eye care, oral and nasal care, podiatry, animal health care, and dermatological conditions in the United States, Europe, Asia, Latin America, and internationally. It offers Lumacyn, a skin toner; Regenacyn, a prescription scar gel; Reliefacyn to alleviate red bumps, rashes, shallow skin fisures, sunburn, peeling, and eczema/atopic dermati...
Sector Healthcare
IPO Date Jan 25, 2007
Employees 10
Stock Exchange NasdaqCM
Ticker Symbol SNOA
Website https://sonomapharma.com
Financial Performance
In 2026, Sonoma Pharmaceuticals's revenue was 19.53M, an increase of 36.68% compared to the previous year's 14.29M. Earnings were -3.18M, a decrease of -8.16%.
Financial StatementsEarnings Surprise
Sonoma Pharmaceuticals has released their quarterly earnings on Feb 10, 2026:
- Revenue of $6.41M misses estimates by $0, with 59.55% YoY growth.
- EPS of -0.48 misses estimates by -0.19, with 18.64% YoY growth.
